Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Efficacy, Self
  • Safety Issues
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: TQB3525 orally takenMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 12 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04690725
Collaborators
Not Provided
Investigators
Principal Investigator: Wei Guo, Ph.D and M.D. Chinese Sarcoma Study Group